TERM ID="NYU_TERM_1" STRING="Cardiotoxicity" FREQUENCY=1 START=0 END=14 LEMMA="CARDIOTOXICITY" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_2" STRING="HER2" FREQUENCY=2 START=56 END=60 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="HER2" FREQUENCY=2 START=177 END=181 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="N-terminal pro-brain B-type natriuretic peptide" FREQUENCY=1 START=925 END=972 LEMMA="N-TERMINAL PRO-BRAIN B-TYPE NATRIURETIC PEPTIDE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="anthracyclines" FREQUENCY=1 START=602 END=616 LEMMA="ANTHRACYCLINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="assessing levels" FREQUENCY=1 START=890 END=906 LEMMA="ASSESSING LEVEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="cardiac changes" FREQUENCY=1 START=654 END=669 LEMMA="CARDIAC CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="cardiac dysfunction" FREQUENCY=2 START=472 END=491 LEMMA="CARDIAC DYSFUNCTION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_9" STRING="cardiac dysfunction" FREQUENCY=2 START=1272 END=1291 LEMMA="CARDIAC DYSFUNCTION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_10" STRING="cardiac events" FREQUENCY=1 START=850 END=864 LEMMA="CARDIAC EVENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="cardiotoxicity" FREQUENCY=4 START=247 END=261 LEMMA="CARDIOTOXICITY" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_12" STRING="cardiotoxicity" FREQUENCY=4 START=372 END=386 LEMMA="CARDIOTOXICITY" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_13" STRING="cardiotoxicity" FREQUENCY=4 START=515 END=529 LEMMA="CARDIOTOXICITY" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_14" STRING="cardiotoxicity" FREQUENCY=4 START=1046 END=1060 LEMMA="CARDIOTOXICITY" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_15" STRING="clinical efficacy" FREQUENCY=1 START=97 END=114 LEMMA="CLINICAL EFFICACY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="epidermal growth factor receptor-2" FREQUENCY=1 START=141 END=175 LEMMA="EPIDERMAL GROWTH FACTOR RECEPTOR-2" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="functional evaluation scheme" FREQUENCY=1 START=1080 END=1108 LEMMA="FUNCTIONAL EVALUATION SCHEME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="heart failure" FREQUENCY=1 START=1245 END=1258 LEMMA="HEART FAILURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="histological changes" FREQUENCY=1 START=773 END=793 LEMMA="HISTOLOGICAL CHANGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="investigation" FREQUENCY=1 START=334 END=347 LEMMA="INVESTIGATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="metastatic breast cancer" FREQUENCY=1 START=184 END=208 LEMMA="METASTATIC BREAST CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="monotherapy" FREQUENCY=2 START=568 END=579 LEMMA="MONOTHERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="monotherapy" FREQUENCY=2 START=1425 END=1436 LEMMA="MONOTHERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_24" STRING="pathogenesis" FREQUENCY=1 START=284 END=296 LEMMA="PATHOGENESI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="preventing cardiotoxicity" FREQUENCY=1 START=1523 END=1548 LEMMA="PREVENTING CARDIOTOXICITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="risk assessment" FREQUENCY=1 START=438 END=453 LEMMA="RISK ASSESSMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="risk factors" FREQUENCY=1 START=833 END=845 LEMMA="RISK FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="risk factors for cardiac events" FREQUENCY=1 START=833 END=864 LEMMA="CARDIAC EVENT RISK FACTOR" LEMMA_FREQUENCY=1 HEAD_TERM="risk factors" HEAD_LEMMA="RISK FACTOR"
TERM ID="NYU_TERM_29" STRING="therapeutic options" FREQUENCY=1 START=1204 END=1223 LEMMA="THERAPEUTIC OPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="trastuzumab" FREQUENCY=6 START=210 END=221 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_31" STRING="trastuzumab" FREQUENCY=6 START=544 END=555 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_32" STRING="trastuzumab" FREQUENCY=6 START=1005 END=1016 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_33" STRING="trastuzumab" FREQUENCY=6 START=1151 END=1162 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_34" STRING="trastuzumab" FREQUENCY=6 START=1308 END=1319 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_35" STRING="trastuzumab" FREQUENCY=6 START=1401 END=1412 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_36" STRING="trastuzumab therapy" FREQUENCY=1 START=619 END=638 LEMMA="TRASTUZUMAB THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="trastuzumab treatment" FREQUENCY=1 START=31 END=52 LEMMA="TRASTUZUMAB TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="trastuzumab treatment of HER2" FREQUENCY=1 START=31 END=60 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 TRASTUZUMAB TREATMENT" LEMMA_FREQUENCY=1 HEAD_TERM="trastuzumab treatment" HEAD_LEMMA="TRASTUZUMAB TREATMENT"
TERM ID="NYU_TERM_39" STRING="trastuzumab use" FREQUENCY=1 START=404 END=419 LEMMA="TRASTUZUMAB USE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="trastuzumab-treated patients" FREQUENCY=1 START=679 END=707 LEMMA="TRASTUZUMAB-TREATED PATIENT" LEMMA_FREQUENCY=1
